Jupiter Asset Management LTD Bristol Myers Squibb CO Transaction History

Jupiter Asset Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $21.8 Million - $26 Million	450,028 New	450,028 $23.1 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $7,757 - $4.59 Million	59,670 New	59,670 $4.24 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $429,040 - $500,160	-8,000 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $374,486 - $438,662	-6,329 Reduced 44.17%	8,000 $473,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $24,082 - $26,226	389 Added 2.79%	14,329 $957,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $827,199 - $930,355	13,940 New	13,940 $880,000
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $309,255 - $350,443	-5,356 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $307,595 - $340,855	5,356 New	5,356 $323,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.